Position in AMGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,494,315,864
+$628,442,726 QoQ
Shares Held
12,773,386
+8.1% QoQ
Ownership
2.37%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.99831681278557.ToString("F0")%
Shared 0.ToString("F0")%
None 0.001683187214415974.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $30,098,800,763 across 16 Drug Manufacturers - General names. AMGN ranks #4 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
49,765,225 | $5,986,258,914 | |
| 2 | LLY |
ELI LILLY & Co
|
5,897,450 | $5,424,297,586 | |
| 3 | JNJ |
Johnson & Johnson
|
19,177,219 | $4,687,679,411 | |
| 4 | AMGN |
Amgen Inc
This page
|
12,773,386 | $4,494,315,864 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
61,115,373 | $3,706,647,372 | |
| 6 | ABBV |
AbbVie Inc.
|
12,967,398 | $2,820,279,389 | |
| 7 | PFE |
Pfizer Inc
|
51,891,636 | $1,457,117,138 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,181,780 | $1,140,294,678 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,494,315,864 | 12,773,386 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,865,873,138 | 11,811,045 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,823,982,706 | 13,550,612 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,600,043,555 | 12,893,677 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,802,761,230 | 12,205,942 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,441,908,626 | 13,205,604 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,393,718,390 | 10,532,629 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,212,221,274 | 10,280,753 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,079,851,477 | 10,832,342 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,993,423,542 | 10,393,110 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,927,843,220 | 10,893,895 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,495,917,313 | 11,241,858 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,601,577,394 | 10,761,437 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,439,212,795 | 9,287,286 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,081,913,862 | 9,236,530 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,177,201,922 | 8,948,631 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,132,777,435 | 8,819,690 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,962,891,371 | 8,725,125 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,735,898,100 | 8,163,170 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,765,246,518 | 7,242,037 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,585,071,225 | 6,370,609 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $639,084,022 | 2,779,593 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $700,561,794 | 2,756,381 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $660,604,943 | 2,800,835 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $578,669,673 | 2,854,386 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||